The relationship between Wegovy and depression isn't definitively established in clinical research, with major trials showing no clear connection
Beyond weight loss, Semaglutide improves several metabolic health markers: Insulin Sensitivity: Improved insulin sensitivity can reduce the risk of insulin resistance, a condition often linked to cancer development
They also act on the digestive system to delay gastric emptying, delaying the release of food from the stomach and modulating brain activity to suppress appetite
It can happen in the lower eye bag region, and in some cases, the upper eyelid
Duration: Preclinical studies have lasted about 4 weeks on average
Healthcare regulators, including the UKs MHRA and NICE, have carefully reviewed the evidence and continue to endorse GLP-1 receptor agonists, provided patients and prescribers remain aware of the very small potential risk and take appropriate precautions